COGT
Cogent Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$30.01
+1.66%Leverage
- Debt / equity
- 0.46x
- Net debt / equity
- 0.12x
- Debt / assets
- 0.29x
- Debt / EBITDA
- -0.66x
- Net debt / EBITDA
- -0.17x
Liquidity & coverage
- Current ratio
- 13.57x
- Quick ratio
- 13.57x
- Cash ratio
- 13.36x
- Interest coverage
- -75.14x
- EBITDA / interest
- -71.91x
- Working capital
- $745.5M
Cash & dividend
- FCF / debt
- -1.27x
- Cash flow / debt
- -1.26x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026